Feel free to contact the Sponsoring Team :
Mathieu RAILLARD
Congress sponsorship manager
mathieu_raillard@yahoo.it
Delphine HOLOPHERNE DORAN
Congress sponsorship manager
delphine.holopherne-doran@ bristolvetspecialists.co.uk
Julien MALLOT
Congress sales executive
j.mallot@clq-group.com
If you would like to join the current sponsors in partnering with the WCVAA 2025 please take a look at :
SUBSCRIBE
to the WCVAA 2025 newsletter
By entering your email address above, you agree to receive WCVAA communications electronically.
You can unsubscribe at any time using the unsubscribe link in the emails sent to you.
For any questions: wcvaa@clq-group.com
Global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. We are a global leader in veterinary endocrinology and topical dermatology, have a broad portfolio of analgesics, anaesthetics and products for the treatment of pain, and we are also recognised as innovators in other specialisations such as the treatment of equine lameness, nutrition and differentiated generics. We have recently launched Zenalpha, a unique and innovative alpha-2 agonist/antagonist product containing medetomidine and vatinoxan for canine sedation and analgesia. Vatinoxan is a peripherally selective alpha-2 antagonist with a unique mechanism of action. Zenalpha provides the effective, reliable sedation and analgesia you expect from an alpha-2 agonist, with reduced adverse effects on the patient’s cardiovascular system and improved organ blood flow.
